Uncategorized

Oral sirolimus in capillary-lymphatic venous malformations and associated syndromes: a case series of 3 patients

03 – Abstract Venous Symposium Europe 2024 [back to abstract list] AUTHOR(S): Eleni Georgiadi1, Dimitrios Tzaninis2, Efthymios Avgerinos3 Affiliations: 1. Faculty of Medicine, National and Kapodistrian University of Athens (NKUA), Mikras Asias 75, Athens, 115 27 Greece. 2. Oncology Clinic, Athens Medical Center, Athens, Greece. 3. Clinic for Vascular and Endovascular Surgery, Athens Medical Center, Athens, Greece BACKGROUND/AIM Capillary-lymphatic-venous malformations (CLVMs) are congenital vascular anomalies that can present with debilitating manifestations. Sirolimus, previously used as an immunosuppressive and antiproliferative agent, has emerged as a complimentary if not first-line treatment of CLVM. MATERIAL/METHODS We present 3 cases of patients with CLVMs,…

Full text

II. Consensus reports

II. Consensus reports UIP consensus report – contraindications to sclerotherapy Kurosh Parsi (Australia) This presentation was a summary of the available literature. Absolute contraindications include previous anaphylaxis to sclerosants and acute deep vein thrombosis. Relative contraindications include deep venous obstruction, peripheral vascular disease, a thrombophilic disorder increasing the risk of deep vein thrombosis, immobility, acute superficial vein thrombosis, pregnancy and breastfeeding, estrogen therapy, hormone replacement therapy, asthma, migraine, systemic disease associated with skin changes, obesity, advanced age, anticoagulation, pelvic tumors causing varicose veins, foramen ovale, and proposed long-distance travel. UIP consensus report – pelvic venous insufficiency Zaza Lazarashvili (Georgia) and…

Full text

Critical need for an iliofemoral venous obstruction classification system

William A. MARSTON Division of Vascular Surgery, Department of Surgery, University of North Carolina School of Medicine, Chapel Hill, NC, USA Abstract Intervention with venous stenting is experiencing a rapid growth due to advances in medical technology and increased awareness of the clinical relevance of the importance of deep venous obstruction. As this field begins to mature, stents specifically designed for the venous system are now available with more being tested in clinical trials. It is becoming clear that the anatomy and variety of venous obstruction is diverse, with the traditional May-Thurner syndrome comprising only a fraction of the cases…

Full text